Skip to main content

Table 2 CD68 and OPG are commonly co-expressed in primary breast tumors

From: Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells

% with moderate/strong CD68 staining

% with moderate/strong OPG staining

Co-occurrence of moderate/strong CD68 and OPG staining

95.7

78.3

35 out of 46 tumors = 76.1%

  1. CD68 and OPG protein levels were assessed by immunohistochemistry in tissue microarray slides containing human patient primary breast cancer samples (see Methods). Two left columns: data is shown as the percentage of samples presenting with moderate/strong CD68 and OPG staining. Right column: co-occurrence of CD68 and OPG staining represent the detection of moderate/strong expression of both CD68 and OPG within the same patient sample